A Multi-Specialty Delphi Consensus on Assessing and Managing Cardiopulmonary Risk in Patients with COPD
Based on the consensus scores, 9 key recommendations were proposed by the steering group. These focus on the need to comprehensively risk stratify and manage COPD patients to help prevent exacerbations. Consensus within this study provides a call to action for the expeditious implementation of the latest COPD guidelines from the Canadian Thoracic Society.
Authors
- Mohit Bhutani (ORCID: https://orcid.org/0000-0002-1911-4169)
- Jean Bourbeau (ORCID: https://orcid.org/0000-0002-7649-038X)
- Alan G. Kaplan (ORCID: https://orcid.org/0000-0001-8795-5528)
- Nathaniel M. Hawkins (ORCID: https://orcid.org/0000-0003-1286-2014)
- Shaun G. Goodman (ORCID: https://orcid.org/0000-0001-8068-2440)
- Peter Lin (ORCID: https://orcid.org/0000-0001-7418-6213)
- Shelley R. Zieroth (ORCID: https://orcid.org/0000-0002-6145-9814)
- Erika Dianne Penz (ORCID: https://orcid.org/0000-0003-2610-8450)
- Subodh Verma
Institutions
- University of British Columbia (CA)
- University of Alberta (CA)
- University of Toronto (CA)
- McGill University Health Centre (CA)
- University of Saskatchewan (CA)
- Canadian Heart Research Centre (CA)
- University of Manitoba (CA)
- McGill University (CA)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/copd.s471952
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Alberta Health Services
- AstraZeneca Canada
- McGill University
- Canadian Thoracic Society
- Covis Pharma
- McGill University Health Centre
- Grifols
- Canadian Institutes of Health Research